Here, we provide the first comprehensive study characterising the global dynamics and function of H2A.Zac at enhancers in prostate cancer and demonstrate that H2A.Zac plays an active role in AR-enhancer function during androgen treatment suggesting an pro-oncogenic role in cancer. The gene discussed is AR; the disease is Familial prostate cancer.